Published: Jun 7, 2026
Written by Klarity Editorial Team
Published: Jun 7, 2026

If you’ve been struggling with binge eating disorder (BED), you’ve likely faced moments of feeling overwhelmed, isolated, or uncertain about where to turn. The good news? Access to treatment has fundamentally changed. In 2025 and into 2026, telehealth has opened doors to care that simply didn’t exist before—connecting you with licensed providers who can evaluate, treat, and prescribe medication for BED from the comfort of your home.
But with headlines about telehealth crackdowns and confusing state-by-state rules, you might be wondering: Is it actually legal for me to get BED medication online? Will my provider need to see me in person? What medications are even available via telehealth?
This guide will walk you through everything you need to know about accessing medication-assisted treatment for binge eating disorder through telehealth—what’s legal, what’s safe, and how to get started.
Binge eating disorder is the most common eating disorder in the United States, affecting millions of people. Unlike other eating disorders, BED doesn’t involve purging behaviors—but it comes with its own serious health consequences, including obesity, diabetes, heart disease, and profound emotional distress.
The hallmarks of BED include:
For many people, BED isn’t just about willpower or ‘eating better.’ It’s a diagnosable mental health condition rooted in complex psychological, biological, and environmental factors. That’s where medication can help.
While therapy (particularly cognitive-behavioral therapy) remains the gold standard for BED treatment, certain medications have shown promise in reducing binge frequency, improving impulse control, and supporting overall recovery. The challenge? Traditional in-person psychiatric care can involve long wait times, limited specialist availability, and the logistical burden of frequent office visits.
Enter telehealth.
The COVID-19 pandemic forced a rapid expansion of telehealth services across the country. Suddenly, regulations that had restricted online prescribing were suspended, and patients discovered they could see doctors via video and receive prescriptions without ever setting foot in a clinic.
Here’s what you need to know about where things stand now:
For non-controlled medications—including the two primary drugs used off-label for BED (Topamax and Wellbutrin)—there has never been a federal restriction on telehealth prescribing. The Ryan Haight Act, which requires an in-person visit before prescribing certain controlled substances via telemedicine, doesn’t apply to these medications.
This means that from a federal standpoint, your provider can legally prescribe Topamax (topiramate) or Wellbutrin (bupropion) based solely on a telehealth evaluation—no in-person exam required.
The only FDA-approved medication specifically for BED is Vyvanse (lisdexamfetamine), a controlled stimulant. The rules for prescribing controlled substances via telehealth are more complex. During the pandemic, the DEA suspended the in-person requirement for controlled substances. That suspension has been extended through December 31, 2026, while the DEA works on permanent rules.
However, most legitimate telehealth providers are not prescribing stimulants for BED online due to regulatory uncertainty and abuse concerns. Instead, they focus on non-controlled alternatives like topiramate and bupropion.
While federal law sets the baseline, each state has its own telehealth regulations. Some states require periodic in-person follow-ups for ongoing telemedicine care, even for non-controlled medications. Others have no such requirements.
Here’s a snapshot of key states:
States with NO in-person requirement for non-controlled meds:
States requiring periodic in-person visits (typically within 12 months):
In these states, you can still start treatment via telehealth, but your provider may need to see you in person (or arrange for you to see a local collaborating provider) within a year if treatment continues.
Let’s talk specifics about what medications telehealth providers can prescribe for binge eating disorder, how they work, and what you need to know about safety.
What it is: Originally approved for seizures and migraine prevention, topiramate has shown effectiveness in reducing binge eating episodes in clinical studies.
How it helps BED: Topiramate appears to reduce impulsive eating behaviors and may help with weight management. It’s thought to work by modulating neurotransmitters involved in appetite and impulse control.
What to expect:
Important safety considerations:
Can it be prescribed via telehealth? Yes, absolutely. Topiramate is not a controlled substance, and there are no federal restrictions on telehealth prescribing.
What it is: An antidepressant also used for smoking cessation. It’s chemically distinct from other antidepressants and has stimulating properties.
How it helps BED: Bupropion may reduce binge eating frequency by affecting dopamine and norepinephrine—brain chemicals involved in reward and impulse control. Some patients also report reduced food cravings.
What to expect:
Important safety considerations:
Can it be prescribed via telehealth? Yes. Bupropion is not a controlled substance and is routinely prescribed via telemedicine across all 50 states.
Your telehealth provider might be a:
Doctors can prescribe these medications in any state where they’re licensed. Most telehealth platforms employ psychiatrists or primary care physicians with mental health experience.
Nurse practitioners are increasingly providing mental health care, and their authority to prescribe varies by state:
Full Practice Authority (34+ states plus DC): NPs can evaluate, diagnose, and prescribe independently without physician oversight. This includes California, New York, Michigan, Wisconsin, Louisiana, Kansas, and many others. Recent additions include Wisconsin and Michigan (both gained full practice authority in 2025).
Collaborative Practice (remaining states): NPs can prescribe but must work under a formal agreement with a physician. This is common in the Southeast—Florida, Texas, Georgia, Alabama, and South Carolina all require collaboration. This doesn’t affect your care quality; it’s just a regulatory requirement.
For non-controlled medications like Topamax and Wellbutrin, NPs in all states can prescribe as long as they follow their state’s collaboration requirements.
PAs work similarly to NPs but with slightly different training. They can prescribe these medications in all states, typically under physician supervision.
What this means for you: When you sign up with a telehealth service like Klarity Health, you might see any of these provider types. All are qualified to evaluate and treat BED with medication. Klarity Health’s providers are licensed in the state where you’re receiving care, ensuring full legal compliance.
A legitimate telehealth evaluation for BED should be thorough—not a quick questionnaire followed by an automatic prescription. Here’s what a quality assessment looks like:
Medical history review:
Mental health assessment:
Eating disorder screening:
Lifestyle factors:
You’re likely a good fit if:
You may need in-person care if:
A good provider will:
Red flags to watch for:
Even though topiramate and bupropion aren’t controlled substances, responsible telehealth providers implement several safety checks:
Most states maintain databases tracking controlled substance prescriptions. While PDMP checks aren’t legally required for non-controlled medications like Topamax and Wellbutrin, many providers still review them to:
Don’t be surprised or offended if your provider asks to review your medication history—it’s a sign of thoroughness.
Telehealth providers are required to verify:
This prevents fraud and ensures regulatory compliance.
You’ll sign a telehealth consent form that outlines:
Read this carefully—it’s your roadmap for the provider relationship.
For non-controlled medications, providers can often write prescriptions with refills (up to 6-12 months depending on state law). However, expect regular follow-up appointments:
Typical schedule:
Some states (Alabama, Georgia, New Hampshire) require at least one in-person visit within 12 months for ongoing telemedicine treatment. Your provider will coordinate this—it can often be done with a local collaborating provider or during a single office visit.
At Klarity Health, we’ve designed our platform specifically to address the barriers that have kept too many people from getting help for conditions like binge eating disorder.
We maintain a network of licensed psychiatrists, psychiatric nurse practitioners, and physician assistants across all 50 states. This means you can typically get an appointment within days—not months.
We believe healthcare costs should never be a mystery. Our pricing is clear upfront:
Our providers don’t just write prescriptions—they partner with you on a treatment plan that may include:
We take your privacy seriously:
Most insurance plans now cover telehealth at the same rate as in-person visits, thanks to pandemic-era policy changes that have been extended. However, coverage specifics vary:
What’s typically covered:
What may not be covered:
Klarity Health’s approach:We verify your insurance benefits upfront so you know what to expect. If your plan doesn’t cover telehealth, we offer competitive self-pay rates that are often comparable to insurance co-pays.
Generic topiramate: Typically $10-30/month with insurance; $20-50/month without
Generic bupropion: Typically $10-40/month with insurance; $30-60/month without
Klarity Health providers can work with you to find the most affordable option, including:
For these medications, extensive lab work isn’t typically required before starting treatment. However, your provider may recommend:
Some providers may request recent lab results if you have other medical conditions. Most of this can be coordinated without an in-person visit.
Your telehealth provider should be accessible between appointments for urgent concerns. At Klarity Health, patients can message their provider through our secure platform. For serious side effects (like signs of an allergic reaction or thoughts of self-harm), emergency protocols are in place.
Common manageable side effects can often be addressed by:
BED treatment is individualized. Some people take medication for several months while building therapy skills, then taper off. Others find longer-term treatment more helpful. Your provider will work with you to find the right duration based on your response and goals.
Absolutely—and it’s encouraged. Medication can help reduce binge frequency and create space for therapy to be more effective. Many patients find the combination of medication and cognitive-behavioral therapy (CBT) provides the best outcomes.
Klarity Health providers can refer you to therapists specializing in eating disorders, or you can work with your existing therapist while managing medication through our platform.
Yes, your BED diagnosis and treatment will be documented in your medical record. This is important for continuity of care and legal/ethical practice. However:
If you have specific privacy concerns (for example, if you’re on a family insurance plan), discuss them with your provider. There may be options to limit what appears on insurance explanations of benefits.
The regulatory landscape continues to evolve:
The DEA is expected to finalize permanent rules for telehealth prescribing of controlled substances by the end of 2026. While this won’t directly affect topiramate and bupropion, it will shape the overall telehealth environment and could eventually expand access to other BED medications.
More states are joining the ‘full practice authority’ movement for nurse practitioners. As of 2025, 34+ states allow NPs to practice independently, up from 28 just a few years ago. This trend increases provider availability for telehealth services.
Several states are also working to standardize telehealth regulations across state lines through interstate compacts, which could eventually make it easier for providers to see patients in multiple states.
Research continues into new medications for BED. As new options become available—and as existing medications gain FDA approval for BED specifically—telehealth will remain a key access point for these treatments.
Telehealth isn’t a perfect fit for everyone, but for many people struggling with BED, it offers:
Advantages:
Limitations:
The bottom line: If you’ve been putting off getting help for binge eating disorder because of access barriers, cost concerns, or scheduling challenges, telehealth removes many of those obstacles. The regulations are clear, the medications are available, and providers are ready to help.
If you’re ready to explore medication-assisted treatment for binge eating disorder, here’s how to get started:
Research providers: Look for telehealth platforms with licensed mental health professionals experienced in eating disorders. Klarity Health specializes in mental health conditions including BED, with providers available in all 50 states.
Check your insurance: Call your insurance company or check your benefits online to understand your telehealth coverage. Many plans now cover telehealth visits at the same rate as in-person care.
Prepare for your evaluation: Before your first appointment, gather:
Be honest and thorough: The more information you provide, the better your provider can tailor treatment to your needs. This isn’t a judgment—it’s a medical evaluation.
Commit to follow-up: Medication is most effective when combined with regular monitoring and support. Plan to attend your scheduled appointments and communicate openly about your progress.
Binge eating disorder is a serious but treatable condition. You didn’t choose to have BED, and struggling with it doesn’t reflect a lack of willpower or self-control. It’s a complex mental health condition that often responds well to the right combination of medication, therapy, and support.
The telehealth infrastructure that emerged during the pandemic has created unprecedented access to specialized care. Whether you’re in a rural area with limited local providers, juggling a demanding schedule, or simply prefer the privacy and convenience of virtual visits, you now have options that didn’t exist just a few years ago.
At Klarity Health, we’ve made it our mission to remove barriers to mental health care. Our providers understand eating disorders, our pricing is transparent (we accept both insurance and self-pay), and our platform is designed for your convenience without sacrificing quality or safety.
If binge eating disorder has been controlling your life, it’s time to take that control back. The first step is often the hardest, but it’s also the most important—and you don’t have to take it alone.
Schedule a consultation with a Klarity Health provider today. Our licensed psychiatrists and psychiatric nurse practitioners are available in all 50 states, with appointments often available within days. We’ll conduct a thorough evaluation, discuss your treatment options (including whether medication might be helpful), and create a personalized plan that fits your life.
Visit Klarity Health to learn more and book your first appointment. Your journey toward recovery can start today—from wherever you are.
U.S. Department of Health & Human Services. (2026, January). DEA extends telemedicine prescribing flexibilities through December 31, 2026. Retrieved from https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard Mullin Richter & Hampton LLP. (2025, August). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. Retrieved from https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Center for Connected Health Policy. (2025). Online prescribing state laws. Retrieved from https://www.cchpca.org/topic/online-prescribing/
Health Jobs Nationwide. (2025). State-by-state guide: Expanding roles for PAs and NPs (Updated 2025). Retrieved from https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
U.S. National Library of Medicine, DailyMed. (2024). Bupropion hydrochloride extended-release tablets – FDA label. Retrieved from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display
📅 RESEARCH CURRENCY STATEMENT
Verified as of: January 4, 2026
DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications.
States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest info as of late 2025.
Sources newer than 2024: 80%+ of sources are 2025 (many late-2025) or updated to 2025.
⚠️ Flagged for follow-up: Alabama and South Carolina NP scope changes (legislation discussed in 2025 but final status unclear). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026).
Find the right provider for your needs — select your state to find expert care near you.